The search results reference VX15, a monoclonal antibody under investigation for Huntington’s disease (HD) in the SIGNAL trial (NCT04558982) . Key details:
| Parameter | Description |
|---|---|
| Target | Semaphorin 4D (SEMA4D) |
| Mechanism | Blocks SEMA4D-mediated inflammation in HD brains |
| Trial Phase | Phase II (Cohort B ongoing) |
| Primary Outcome | Safety, tolerability, and cognitive/motor function changes |
| Secondary Outcomes | Biomarkers of neuroinflammation and neuronal health |
Note: "VX15" is distinct from "CHX15," but its clinical context aligns with potential therapeutic antibody research.
CBX1 (Chromobox Protein Homolog 1) is a histone H3K9 methyl-binding protein critical for heterochromatin formation. Antibodies targeting CBX1 are widely used in epigenetics research:
Clinical Relevance: Elevated CBX1 antibodies (e.g., CBX1-Abs) correlate with cerebrovascular incidents (e.g., transient ischemic attack, acute cerebral infarction) .
CHD1 (Chromodomain Helicase DNA Binding Protein 1) regulates chromatin remodeling. Antibodies targeting CHD1 are used in cancer and neurodegenerative studies:
| Antibody | Source | Applications | Key Findings | References |
|---|---|---|---|---|
| A01175-1 (Rabbit Picoband®) | Boster Bio | WB, IHC, ELISA, Flow Cytometry | Detects CHD1 in brain tissue; validated in paraffin-embedded sections |
Specificity Issues: ~50% of commercial antibodies fail in one or more applications (e.g., Western blot, immunofluorescence) .
Recombinant vs. Conventional Antibodies: Recombinant antibodies outperform monoclonal/polyclonal ones in cross-application performance .
KO Cell Line Validation: Knockout (KO) cell lines are superior controls for antibody specificity, reducing false positives in assays .
Nomenclature Standardization: Confirm the correct target (e.g., SEMA4D, CBX1, CHD1) to align with established literature.
Collaborative Validation: Leverage initiatives like YCharOS to test antibody performance across applications .
Clinical Translation: For HD, prioritize antibodies targeting neuroinflammatory pathways (e.g., SEMA4D, IL-6) .
CHX15 Antibody is a Rabbit Polyclonal antibody that specifically recognizes antigens from Arabidopsis thaliana, particularly those associated with the CATION/H+ EXCHANGER 15 gene (ATCHX15). As a polyclonal antibody, it contains a heterogeneous mixture of antibodies that recognize multiple epitopes on the target antigen, providing robust detection capabilities across different experimental conditions. The antibody targets proteins involved in cation/H+ exchange mechanisms in plant cells, which play crucial roles in cellular pH regulation and ion homeostasis .
CHX15 Antibody has been validated for several key molecular biology applications. These include Enzyme Immunoassay (EIA), general immunoassay protocols, Enzyme-Linked Immunosorbent Assay (ELISA), and Western Blot techniques. The antibody has shown particular effectiveness in detecting recombinant immunogen proteins and peptides in Western Blot applications, making it a versatile tool for diverse experimental approaches in plant molecular biology research .
Proper sample preparation is critical for optimal CHX15 Antibody performance. For plant tissue samples, researchers should consider:
Fresh tissue extraction using appropriate buffer systems that maintain protein integrity while minimizing proteolytic degradation
Inclusion of protease inhibitors and reducing agents in extraction buffers
Careful temperature control during extraction (typically 4°C)
Centrifugation parameters that separate cellular debris while retaining target proteins
Protein quantification prior to antibody application to ensure consistent loading
The performance of the antibody may vary depending on whether samples are native, denatured, or fixed, with Western Blot applications typically requiring denatured proteins while some immunoassays may perform better with native conformations.
Rigorous experimental design with CHX15 Antibody requires multiple controls:
Positive control: Use of known CHX15-expressing Arabidopsis thaliana samples or recombinant CHX15 protein
Negative control: Samples from CHX15 knockout plants or tissues known not to express CHX15
Antibody controls: Secondary antibody-only controls to assess non-specific binding
Loading controls: Housekeeping proteins (e.g., actin, tubulin) for Western Blot normalization
Blocking peptide control: Pre-incubation of antibody with synthetic CHX15 peptide to confirm specificity
These controls help distinguish specific signals from background and validate experimental findings, particularly important given the polyclonal nature of this antibody.
For optimal Western Blot detection of CHX15 in plant samples, researchers should consider:
Sample preparation: Use SDS-based lysis buffers containing DTT or β-mercaptoethanol as reducing agents
Gel percentage: 10-12% polyacrylamide gels typically provide good resolution for CHX15 detection
Transfer conditions: Semi-dry transfer (15-20V for 30-45 minutes) or wet transfer (30V overnight at 4°C)
Blocking: 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature
Primary antibody: Dilute CHX15 Antibody 1:1000 to 1:2000 in blocking solution; incubate overnight at 4°C
Washing: 3-5 washes with TBST, 5-10 minutes each
Secondary antibody: Anti-rabbit HRP-conjugated secondary antibody at 1:5000 to 1:10000 dilution
Detection: Use enhanced chemiluminescence (ECL) substrate with exposure times optimized for signal intensity
Optimization may be required for specific research questions, including adjusting antibody concentrations and incubation times based on signal strength and background levels.
CHX15 Antibody enables sophisticated studies of cation/H+ exchange mechanisms through:
Immunolocalization studies to determine subcellular localization of CHX15 exchangers
Co-immunoprecipitation experiments to identify protein interaction partners
Comparative expression analysis across different plant tissues and developmental stages
Investigation of CHX15 expression changes under ionic stress conditions
Combined approaches with electrophysiological measurements to correlate protein presence with functional activity
These applications provide insights into how plants regulate cellular pH and ion homeostasis, which are essential for understanding plant responses to environmental stresses such as salinity and drought.
When faced with contradictory results using CHX15 Antibody, researchers should implement a systematic troubleshooting approach:
Antibody validation: Verify antibody specificity using Western Blot against recombinant CHX15 protein
Multiple detection methods: Compare results across different techniques (ELISA, Western Blot, immunofluorescence)
Technical replication: Perform experiments with consistent protocols across multiple independent samples
Biological validation: Correlate antibody-based detection with gene expression analysis (RT-qPCR)
Alternative antibody sources: Compare results with independently produced CHX15 antibodies if available
Epitope mapping: Determine which regions of CHX15 are recognized by the polyclonal antibody
Literature comparison: Contextualize findings within published research on CHX15 and related cation/H+ exchangers
This methodical approach helps distinguish between technical artifacts and genuine biological variability.
CHX15 Antibody provides valuable tools for investigating plant stress responses:
Time-course experiments examining CHX15 protein expression during exposure to salt, drought, or pH stress
Comparative protein abundance measurement across wild-type and stress-tolerant plant varieties
Correlation of CHX15 protein levels with physiological parameters of stress tolerance
Investigation of post-translational modifications of CHX15 under different stress conditions
Integration with transcriptomic data to understand regulatory mechanisms controlling CHX15 expression
These approaches help elucidate the role of cation/H+ exchangers in plant adaptation to environmental challenges, potentially informing strategies for developing stress-resistant crops.
Non-specific binding can complicate CHX15 Antibody experiments. Researchers can mitigate this through:
Optimization of blocking conditions: Test different blocking agents (milk, BSA, casein) and concentrations
Increasing wash stringency: Use higher detergent concentrations or longer wash steps
Antibody dilution optimization: Titrate primary antibody to find optimal signal-to-noise ratio
Pre-adsorption: Incubate antibody with proteins from non-target tissues to remove cross-reactive antibodies
Reducing primary antibody incubation time or temperature
Using more specific detection systems with lower background
If persistent non-specific binding occurs, researchers should consider using monoclonal antibodies or affinity-purified antibody preparations if available.
Verifying CHX15 Antibody specificity requires multiple approaches:
Western Blot analysis showing bands of expected molecular weight
Comparison of signals between wild-type and CHX15 knockout or knockdown plants
Peptide competition assays demonstrating signal reduction with specific blocking peptides
Mass spectrometry identification of immunoprecipitated proteins
Correlation between protein detection and known gene expression patterns
Signal absence in tissues that naturally lack CHX15 expression
Consistent results across different sample preparation methods
These verification steps are essential before embarking on extensive research projects using the CHX15 Antibody.
CHX15 Antibody offers opportunities to investigate membrane trafficking processes:
Immunofluorescence microscopy to track CHX15 localization during vesicle trafficking
Subcellular fractionation followed by immunoblotting to identify membrane compartments containing CHX15
Co-localization studies with known membrane markers to define CHX15 trafficking pathways
Live-cell imaging using CHX15 Antibody-derived Fab fragments
Combination with inhibitors of membrane trafficking to assess impact on CHX15 distribution
These approaches help understand how plant cells regulate the distribution of ion transporters in response to developmental cues and environmental stimuli.
When incorporating CHX15 Antibody into multiplex assays, researchers should consider:
Antibody cross-reactivity: Test for potential interactions with other primary antibodies in the multiplex panel
Secondary antibody compatibility: Ensure secondary antibodies with minimal cross-species reactivity
Signal intensity balancing: Adjust concentrations of each primary antibody to achieve comparable signal strength
Spectral overlap: Choose fluorophores with minimal spectral overlap for immunofluorescence applications
Sequential detection protocols: Consider sequential rather than simultaneous antibody incubations if cross-reactivity occurs
Control samples: Include single-antibody controls alongside multiplex experiments
These considerations help generate reliable data from complex experimental setups investigating multiple proteins simultaneously.